![](https://webarchive.library.unt.edu/eot2008/20090114054511im_/http://www.cancer.gov/images/spacer.gif) |
Title
![](https://webarchive.library.unt.edu/eot2008/20090114054511im_/http://www.cancer.gov/images/spacer.gif) |
![](https://webarchive.library.unt.edu/eot2008/20090114054511im_/http://www.cancer.gov/images/spacer.gif) |
![](https://webarchive.library.unt.edu/eot2008/20090114054511im_/http://www.cancer.gov/images/spacer.gif) |
![](https://webarchive.library.unt.edu/eot2008/20090114054511im_/http://www.cancer.gov/images/spacer.gif) |
Phase ![sort descending](https://webarchive.library.unt.edu/eot2008/20090114054511im_/http://www.cancer.gov/images/arrow_down.gif)
![](https://webarchive.library.unt.edu/eot2008/20090114054511im_/http://www.cancer.gov/images/spacer.gif) |
![](https://webarchive.library.unt.edu/eot2008/20090114054511im_/http://www.cancer.gov/images/spacer.gif) |
![](https://webarchive.library.unt.edu/eot2008/20090114054511im_/http://www.cancer.gov/images/spacer.gif) |
![](https://webarchive.library.unt.edu/eot2008/20090114054511im_/http://www.cancer.gov/images/spacer.gif) |
Protocol
IDs
![](https://webarchive.library.unt.edu/eot2008/20090114054511im_/http://www.cancer.gov/images/spacer.gif) |
![](https://webarchive.library.unt.edu/eot2008/20090114054511im_/http://www.cancer.gov/images/spacer.gif) |
![](https://webarchive.library.unt.edu/eot2008/20090114054511im_/http://www.cancer.gov/images/spacer.gif) |
|
![](https://webarchive.library.unt.edu/eot2008/20090114054511im_/http://www.cancer.gov/images/spacer.gif)
Intravenous or Hepatic Arterial Infusion of Fotemustine in Treating Patients With Unresectable Liver Metastases From Eye Melanoma
![](https://webarchive.library.unt.edu/eot2008/20090114054511im_/http://www.cancer.gov/images/spacer.gif)
|
|
![](https://webarchive.library.unt.edu/eot2008/20090114054511im_/http://www.cancer.gov/images/spacer.gif) |
|
![](https://webarchive.library.unt.edu/eot2008/20090114054511im_/http://www.cancer.gov/images/spacer.gif)
Phase III
![](https://webarchive.library.unt.edu/eot2008/20090114054511im_/http://www.cancer.gov/images/spacer.gif)
|
|
![](https://webarchive.library.unt.edu/eot2008/20090114054511im_/http://www.cancer.gov/images/spacer.gif) |
|
![](https://webarchive.library.unt.edu/eot2008/20090114054511im_/http://www.cancer.gov/images/spacer.gif)
EORTC-18021
EUDRACT-2004-002245-12, NCT00110123
![](https://webarchive.library.unt.edu/eot2008/20090114054511im_/http://www.cancer.gov/images/spacer.gif)
|
|
|
![](https://webarchive.library.unt.edu/eot2008/20090114054511im_/http://www.cancer.gov/images/spacer.gif)
Hepatic Arterial Infusion With Melphalan Compared With Standard Therapy in Treating Patients With Unresectable Liver Metastases Due to Melanoma
![](https://webarchive.library.unt.edu/eot2008/20090114054511im_/http://www.cancer.gov/images/spacer.gif)
|
|
![](https://webarchive.library.unt.edu/eot2008/20090114054511im_/http://www.cancer.gov/images/spacer.gif) |
|
![](https://webarchive.library.unt.edu/eot2008/20090114054511im_/http://www.cancer.gov/images/spacer.gif)
Phase III
![](https://webarchive.library.unt.edu/eot2008/20090114054511im_/http://www.cancer.gov/images/spacer.gif)
|
|
![](https://webarchive.library.unt.edu/eot2008/20090114054511im_/http://www.cancer.gov/images/spacer.gif) |
|
![](https://webarchive.library.unt.edu/eot2008/20090114054511im_/http://www.cancer.gov/images/spacer.gif)
NCI-06-C-0088
NCI-P6701, NCT00324727
![](https://webarchive.library.unt.edu/eot2008/20090114054511im_/http://www.cancer.gov/images/spacer.gif)
|
|
|
![](https://webarchive.library.unt.edu/eot2008/20090114054511im_/http://www.cancer.gov/images/spacer.gif)
Lucentis as an Adjuvanct Therapy With TTT-ICG Based in Choroidal Melanoma
![](https://webarchive.library.unt.edu/eot2008/20090114054511im_/http://www.cancer.gov/images/spacer.gif)
|
|
![](https://webarchive.library.unt.edu/eot2008/20090114054511im_/http://www.cancer.gov/images/spacer.gif) |
|
![](https://webarchive.library.unt.edu/eot2008/20090114054511im_/http://www.cancer.gov/images/spacer.gif)
Phase III
![](https://webarchive.library.unt.edu/eot2008/20090114054511im_/http://www.cancer.gov/images/spacer.gif)
|
|
![](https://webarchive.library.unt.edu/eot2008/20090114054511im_/http://www.cancer.gov/images/spacer.gif) |
|
![](https://webarchive.library.unt.edu/eot2008/20090114054511im_/http://www.cancer.gov/images/spacer.gif)
FVF4290s
NCT00680225
![](https://webarchive.library.unt.edu/eot2008/20090114054511im_/http://www.cancer.gov/images/spacer.gif)
|
|
|
![](https://webarchive.library.unt.edu/eot2008/20090114054511im_/http://www.cancer.gov/images/spacer.gif)
Comparative Study of Individualized Sensitivity-Directed Chemotherapy Versus DTIC
![](https://webarchive.library.unt.edu/eot2008/20090114054511im_/http://www.cancer.gov/images/spacer.gif)
|
|
![](https://webarchive.library.unt.edu/eot2008/20090114054511im_/http://www.cancer.gov/images/spacer.gif) |
|
![](https://webarchive.library.unt.edu/eot2008/20090114054511im_/http://www.cancer.gov/images/spacer.gif)
Phase III
![](https://webarchive.library.unt.edu/eot2008/20090114054511im_/http://www.cancer.gov/images/spacer.gif)
|
|
![](https://webarchive.library.unt.edu/eot2008/20090114054511im_/http://www.cancer.gov/images/spacer.gif) |
|
![](https://webarchive.library.unt.edu/eot2008/20090114054511im_/http://www.cancer.gov/images/spacer.gif)
101.321-13/07
EudraCT Nr. 2008-001686-28, NCT00779714
![](https://webarchive.library.unt.edu/eot2008/20090114054511im_/http://www.cancer.gov/images/spacer.gif)
|
|
|
![](https://webarchive.library.unt.edu/eot2008/20090114054511im_/http://www.cancer.gov/images/spacer.gif)
Calcitriol and Temozolomide in Treating Patients With Metastatic Melanoma
![](https://webarchive.library.unt.edu/eot2008/20090114054511im_/http://www.cancer.gov/images/spacer.gif)
|
|
![](https://webarchive.library.unt.edu/eot2008/20090114054511im_/http://www.cancer.gov/images/spacer.gif) |
|
![](https://webarchive.library.unt.edu/eot2008/20090114054511im_/http://www.cancer.gov/images/spacer.gif)
Phase II, Phase I
![](https://webarchive.library.unt.edu/eot2008/20090114054511im_/http://www.cancer.gov/images/spacer.gif)
|
|
![](https://webarchive.library.unt.edu/eot2008/20090114054511im_/http://www.cancer.gov/images/spacer.gif) |
|
![](https://webarchive.library.unt.edu/eot2008/20090114054511im_/http://www.cancer.gov/images/spacer.gif)
NU-05M1
NU-0310-093, SPRI-NU-05M1, NCT00301067
![](https://webarchive.library.unt.edu/eot2008/20090114054511im_/http://www.cancer.gov/images/spacer.gif)
|
|
|
![](https://webarchive.library.unt.edu/eot2008/20090114054511im_/http://www.cancer.gov/images/spacer.gif)
Vaccine Therapy and Autologous Lymphocyte Infusion With or Without Fludarabine in Treating Patients With Metastatic Melanoma
![](https://webarchive.library.unt.edu/eot2008/20090114054511im_/http://www.cancer.gov/images/spacer.gif)
|
|
![](https://webarchive.library.unt.edu/eot2008/20090114054511im_/http://www.cancer.gov/images/spacer.gif) |
|
![](https://webarchive.library.unt.edu/eot2008/20090114054511im_/http://www.cancer.gov/images/spacer.gif)
Phase II, Phase I
![](https://webarchive.library.unt.edu/eot2008/20090114054511im_/http://www.cancer.gov/images/spacer.gif)
|
|
![](https://webarchive.library.unt.edu/eot2008/20090114054511im_/http://www.cancer.gov/images/spacer.gif) |
|
![](https://webarchive.library.unt.edu/eot2008/20090114054511im_/http://www.cancer.gov/images/spacer.gif)
MCC-13649
LAC-USC-10M-05-2, 6241, NCI-6241, LAC-USC-HS-05-00068, NCT00313508
![](https://webarchive.library.unt.edu/eot2008/20090114054511im_/http://www.cancer.gov/images/spacer.gif)
|
|
|
![](https://webarchive.library.unt.edu/eot2008/20090114054511im_/http://www.cancer.gov/images/spacer.gif)
Monoclonal Antibody Therapy and Vaccine Therapy in Treating Patients With Resected Stage III or Stage IV Melanoma
![](https://webarchive.library.unt.edu/eot2008/20090114054511im_/http://www.cancer.gov/images/spacer.gif)
|
|
![](https://webarchive.library.unt.edu/eot2008/20090114054511im_/http://www.cancer.gov/images/spacer.gif) |
|
![](https://webarchive.library.unt.edu/eot2008/20090114054511im_/http://www.cancer.gov/images/spacer.gif)
Phase II
![](https://webarchive.library.unt.edu/eot2008/20090114054511im_/http://www.cancer.gov/images/spacer.gif)
|
|
![](https://webarchive.library.unt.edu/eot2008/20090114054511im_/http://www.cancer.gov/images/spacer.gif) |
|
![](https://webarchive.library.unt.edu/eot2008/20090114054511im_/http://www.cancer.gov/images/spacer.gif)
MCC-15241
MDX-010-16, NCI-6446, 6446, NCT00084656, LAC-USC-10M036
![](https://webarchive.library.unt.edu/eot2008/20090114054511im_/http://www.cancer.gov/images/spacer.gif)
|
|
|
![](https://webarchive.library.unt.edu/eot2008/20090114054511im_/http://www.cancer.gov/images/spacer.gif)
Hepatic Arterial Infusion of Melphalan With Hepatic Perfusion in Treating Patients With Unresectable Liver Cancer
![](https://webarchive.library.unt.edu/eot2008/20090114054511im_/http://www.cancer.gov/images/spacer.gif)
|
|
![](https://webarchive.library.unt.edu/eot2008/20090114054511im_/http://www.cancer.gov/images/spacer.gif) |
|
![](https://webarchive.library.unt.edu/eot2008/20090114054511im_/http://www.cancer.gov/images/spacer.gif)
Phase II
![](https://webarchive.library.unt.edu/eot2008/20090114054511im_/http://www.cancer.gov/images/spacer.gif)
|
|
![](https://webarchive.library.unt.edu/eot2008/20090114054511im_/http://www.cancer.gov/images/spacer.gif) |
|
![](https://webarchive.library.unt.edu/eot2008/20090114054511im_/http://www.cancer.gov/images/spacer.gif)
NCI-04-C-0273
NCI-6332, DELCATH-G990039, NCT00096083
![](https://webarchive.library.unt.edu/eot2008/20090114054511im_/http://www.cancer.gov/images/spacer.gif)
|
|
|
![](https://webarchive.library.unt.edu/eot2008/20090114054511im_/http://www.cancer.gov/images/spacer.gif)
Taxoprexin® Treatment for Advanced Eye Melanoma
![](https://webarchive.library.unt.edu/eot2008/20090114054511im_/http://www.cancer.gov/images/spacer.gif)
|
|
![](https://webarchive.library.unt.edu/eot2008/20090114054511im_/http://www.cancer.gov/images/spacer.gif) |
|
![](https://webarchive.library.unt.edu/eot2008/20090114054511im_/http://www.cancer.gov/images/spacer.gif)
Phase II
![](https://webarchive.library.unt.edu/eot2008/20090114054511im_/http://www.cancer.gov/images/spacer.gif)
|
|
![](https://webarchive.library.unt.edu/eot2008/20090114054511im_/http://www.cancer.gov/images/spacer.gif) |
|
![](https://webarchive.library.unt.edu/eot2008/20090114054511im_/http://www.cancer.gov/images/spacer.gif)
P01-04-22
NCT00244816
![](https://webarchive.library.unt.edu/eot2008/20090114054511im_/http://www.cancer.gov/images/spacer.gif)
|
|
|
![](https://webarchive.library.unt.edu/eot2008/20090114054511im_/http://www.cancer.gov/images/spacer.gif)
Iodine I 131 Monoclonal Antibody 3F8 in Treating Patients With Central Nervous System Cancer or Leptomeningeal Cancer
![](https://webarchive.library.unt.edu/eot2008/20090114054511im_/http://www.cancer.gov/images/spacer.gif)
|
|
![](https://webarchive.library.unt.edu/eot2008/20090114054511im_/http://www.cancer.gov/images/spacer.gif) |
|
![](https://webarchive.library.unt.edu/eot2008/20090114054511im_/http://www.cancer.gov/images/spacer.gif)
Phase II
![](https://webarchive.library.unt.edu/eot2008/20090114054511im_/http://www.cancer.gov/images/spacer.gif)
|
|
![](https://webarchive.library.unt.edu/eot2008/20090114054511im_/http://www.cancer.gov/images/spacer.gif) |
|
![](https://webarchive.library.unt.edu/eot2008/20090114054511im_/http://www.cancer.gov/images/spacer.gif)
MSKCC-05122
NCT00445965
![](https://webarchive.library.unt.edu/eot2008/20090114054511im_/http://www.cancer.gov/images/spacer.gif)
|
|